Biotech firm Windtree Therapeutics plans to acquire up to $700 million in BNB cryptocurrency, following the coin's recent all-time high price. The company, traded on Nasdaq as WINT, is raising funds through a $500 million equity line of credit and a $20 million stock-purchase agreement to facilitate these acquisitions. Windtree had initially announced a $200 million purchase plan before increasing its commitment. With BNB being the fifth-largest cryptocurrency, Windtree's CEO emphasized the need for additional funds to bolster their cryptocurrency strategy. This move reflects a growing trend among publicly traded companies, like Software firm Strategy, that are amassing crypto assets to potentially enhance their stock valuations. Windtree's stock has seen significant growth recently, despite a slight drop following the announcement.

Source 🔗